Bottom line
VHCIX vs RYHIX: the short answer
VHCIX (Vanguard Health Care Index Fund) and RYHIX (Health Care Fund) are both mutual funds.
But VHCIX is far broader, holding 407 positions to 135 for RYHIX, so beyond the top names it adds exposure RYHIX doesn't have.
VHCIX is cheaper at 0.09% vs 1.38% — a difference of $129 a year per $10,000 invested.
Over five years, VHCIX returned +7.2% a year vs +5.1% for RYHIX (reporting dates differ).
Updated Nov 19, 2026
VHCIX vs RYHIX side by side
| VHCIX | RYHIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Vanguard | Guggenheim |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.09% | 1.38% |
| Annual cost per $10k | $9 | $138 |
| 10-yr cost on $10k (prospectus) | $115 | $1,709 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +2.7% | +14.4% |
| 5-yr return (annualized) | +7.2% | +5.1% |
| 10-yr return (annualized) | +8.8% | +7.9% |
| Best quarter | +16.5% | +18.7% |
| Worst quarter | −13.1% | −14.4% |
| Net assets (fund) | $19.0B | $19.4M |
| Number of holdings | 407 | 135 |
| Portfolio turnover | 4% | 244% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | VHCIX | RYHIX | Difference |
|---|---|---|---|
| 2024 | +2.7% | +0.6% | +2.0% |
| 2023 | +2.5% | +5.8% | −3.4% |
| 2022 | −5.5% | −11.6% | +6.1% |
| 2021 | +20.5% | +19.2% | +1.3% |
| 2020 | +18.2% | +18.9% | −0.7% |
| 2019 | +22.0% | +22.8% | −0.8% |
| 2018 | +5.6% | +1.6% | +4.0% |
| 2017 | +23.4% | +23.5% | −0.1% |
| 2016 | −3.3% | −9.4% | +6.0% |
Source: Fund prospectus bar charts
Holdings overlap
23 of VHCIX's top 25 holdings also appear in RYHIX's top 25.
| Holding | VHCIX | RYHIX |
|---|---|---|
| Eli Lilly & Co | 14.04% | 3.63% |
| Johnson & Johnson | 8.47% | 2.88% |
| AbbVie Inc | 6.09% | 2.52% |
| UnitedHealth Group Inc | 5.45% | 2.22% |
| Merck & Co Inc | 4.66% | 2.04% |
| Thermo Fisher Scientific Inc | 2.93% | 1.61% |
| Amgen Inc | 2.87% | 1.56% |
| Gilead Sciences Inc | 2.64% | 1.39% |
| Intuitive Surgical Inc | 2.38% | 1.31% |
| Pfizer Inc | 2.35% | 1.25% |
| Abbott Laboratories | 2.35% | 1.42% |
| Bristol-Myers Squibb Co | 1.84% | 1.22% |
| Danaher Corp | 1.84% | 1.30% |
| CVS Health Corp | 1.83% | 1.31% |
| Vertex Pharmaceuticals Inc | 1.80% | 1.34% |
Source: SEC Form N-PORT
VHCIX top 10
- Eli Lilly & Co — 14.04%
- Johnson & Johnson — 8.47%
- AbbVie Inc — 6.09%
- UnitedHealth Group Inc — 5.45%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 2.93%
- Amgen Inc — 2.87%
- Gilead Sciences Inc — 2.64%
- Intuitive Surgical Inc — 2.38%
- Pfizer Inc — 2.35%
RYHIX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
FAQ
What is the difference between VHCIX and RYHIX?
Which is cheaper, VHCIX or RYHIX?
Should I own both VHCIX and RYHIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.